Home / Gilead Sciences

Gilead Sciences

Gilead announces steps to expand availability of Remdesivir in India

2 min read Last Updated : Apr 27 2021 | 6:31 AM IST

Gilead to acquire German biotech firm MYR for about 1.15 billion euros

1 min read Last Updated : Dec 10 2020 | 7:11 PM IST

Premium

WHO advises doctors against using Gilead's remdesivir for treating Covid-19

5 min read Last Updated : Nov 20 2020 | 9:27 PM IST

Top intensive care body advises against Remdesivir for Covid-19 patients

4 min read Last Updated : Nov 13 2020 | 3:58 PM IST

Premium

DCGI rejects DRL's proposal, denies full marketing rights for Remdesivir

2 min read Last Updated : Nov 02 2020 | 8:18 PM IST

Premium

USFDA approves Remdesivir as first Covid-19 therapy amid WHO reservations

4 min read Last Updated : Oct 23 2020 | 1:59 PM IST

Premium

Remdesivir, HCQ don't aid much in recovery of Covid-19 patients: WHO trials

4 min read Last Updated : Oct 16 2020 | 10:31 AM IST

Europe buys 500,000 courses of Gilead's remdesivir amid supply worries

2 min read Last Updated : Oct 08 2020 | 2:49 PM IST

Premium

Covid-19: Liquid form of remdesivir to smoothen supply, says industry

3 min read Last Updated : Sep 30 2020 | 6:05 AM IST

Gilead Sciences to pay $97 million to settle US govt kickback probe

2 min read Last Updated : Sep 24 2020 | 8:39 AM IST